We found that most of the tumors presented a high expression of IDO1 molecule (101; 56%, Figure 2a), both among adenocarcinomas (65; 55%) and squamous cell carcinomas (36; 58%). This evidence concerns the gene IDO1 and squamous cell carcinoma.